• Pay My Bill
  • Careers
  • Donate
  • My Health Record
  • +1 (401) 274-1100

Site Search

Linda Nelson named fellow of American Society of Health System Pharmacists

Release Date: 07/26/2016

Linda A. Nelson, PharmD, BCCCP, a clinical pharmacy specialist in the Integrated Program for High-Risk Pregnancy at Women & Infants Hospital of Rhode Island, a Care New England hospital, was recently named a fellow of the American Society of Health System Pharmacists (ASHP). Dr. Nelson is also co-director of Women & Infants’ Antimicrobial Stewardship Program and an adjunct clinical associate professor of pharmacy practice at the University of Rhode Island (URI) College of Pharmacy.

The ASHP Practitioner Recognition Program recognizes excellence in pharmacy practice and promotes public awareness of pharmacists who have distinguished themselves in practice. Fellows have made significant contributions to health system pharmacy practice, have contributed extensively to the professional literature, and have presented at professional meetings and been involved in professional activities.

Dr. Nelson has devoted her career to creating functional, sustainable, value-added services that promote the unique and collaborative contributions of pharmacists in emergency medicine, ambulatory care, critical care, high-risk pregnancy, and antimicrobial stewardship. She has pioneered efforts in collaborative drug therapy management and has developed an ambulatory care specialty residency and a critical care residency. She has published in peer- reviewed journals and has been recognized for contributions to quality and safety in health care. Dr. Nelson is an active member of ASHP and is currently serving as chair of the ASHP Commission on Affiliate Relations. Prior to this, she served as a member of the ASHP Section of Clinical Specialists and Scientists (SCSS) Educational Steering Committee and as a delegate to the ASHP House of Delegates. Dr. Nelson has served on the Rhode Island Society of Health System Pharmacists (RISHP) Board of Directors for six years. During her term as RISHP president in 2011, she collaborated with URI faculty to establish a statewide Antimicrobial Stewardship Task Force. Dr. Nelson was recognized with the RISHP Health System Pharmacist of the Year Award in 2013.

A graduate of the University of Rhode Island, Dr. Nelson earned a doctor of pharmacy degree at the Philadelphia College of Pharmacy and Science. She achieved certification in advanced antimicrobial stewardship (MAD-ID) and is a specialist critical care pharmacist (BCCP).

 

 

About Women & Infants Hospital 

Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the 9th largest stand-alone obstetrical service in the country and the largest in New England with approximately 8,500 deliveries per year. A Designated Baby-Friendly® USA hospital, U.S.News & World Report 2014-15 Best Children’s Hospital in Neonatology and a 2014 Leapfrog Top Hospital, in 2009 Women & Infants opened what was at the time the country’s largest, single-family room neonatal intensive care unit.

Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.